Israel launches strikes on missile facilities in central Iran: air force Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy ...

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...

Panelists discuss how to select among the four available JAK inhibitors (Ruxolitinib, Fedratinib, Pacritinib, and Momelotinib) based on patient-specific factors such as anemia, thrombocytopenia, and ...

First clinical data for INCA033989, a novel monoclonal antibody from Incyte (Nasdaq: INCY) targeting CALR-mutant ...

Qiagen and Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...

its last official publication was in 1997 141 and its activities are summarized in a superb book entitled Polycythemia Vera and the Myeloproliferative Disorders, edited by Louis Wasserman ...

“Further research is expected to contribute to the diagnosis, treatment, and prognosis of [myeloproliferative neoplasms ... of resource pages at BioNews Services before joining Rare Disease Advisor.

Discover chronic myeloproliferative disorders—their types, causes, symptoms, diagnosis methods, and treatment options to help manage the condition effectively ...

Myeloproliferative disorders (MPDs) are a group of blood cancers traditionally treated using medications, blood filtration, and chemotherapy or radiation. In recent news, several studies and ...

Clinical trials offer a unique treatment experience when you live with myeloproliferative disorders. Lower cost of care, direct access to a specialized MDS medical team, and the opportunity to try ...

Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers involving the uncontrolled replication of cells derived from myeloid stem cells.